Manufacturing and R&D in Microbiome Therapies
Ferring Microbiome Inc. advances the science and production of microbiome-based therapeutics, focusing on restoring healthy gut flora using cutting-edge solutions like the proprietary MRT™ platform. Our team drives innovations from concept to manufacturing, supporting breakthroughs in gut health and personalized medicine. We collaborate with partners, researchers, and healthcare stakeholders to move these critical therapies forward.
Company information
01 / What we do
We focus on innovative microbiome solutions across research, platform development, biomanufacturing, and support for translational applications. Each service addresses unique aspects of creating and delivering effective microbiome-based therapies, with a core commitment to rigor, safety, and scalability.
Our R&D activities explore the fundamental and translational science of the human gut microbiome. We conduct investigations into microbial diversity, interactions, and therapeutic mechanisms, enabling discovery and preclinical development of new microbiome-based interventions. Our research supports both internal programs and collaborative projects, building a solid scientific foundation for future therapies.
Discuss your idea ↗
At the heart of our innovation is the proprietary MRT™ platform, designed to restore and modulate healthy gut microflora. We engineer and optimize this technology for select indications, offering a pathway to personalized and effective microbiome-based treatments. The platform’s modular design supports flexible applications and integration into various clinical or research pipelines.
Discuss your idea ↗
We specialize in the scalable manufacturing of microbiome therapeutic products using robust quality systems. Our manufacturing suite is built to support rigorous protocols, ensuring safety, reproducibility, and regulatory compliance. The facility can accommodate contract manufacturing, technology transfer, and the production needs of both pilot and commercial-scale programs.
Discuss your idea ↗Bridging laboratory and clinic, we offer support services to facilitate the transition from discovery to clinical application. This includes assistance with preclinical studies, protocol optimization, and navigating regulatory pathways. We work with research sponsors to clarify manufacturability, technical requirements, and preparation for regulatory submissions surrounding microbiome-based therapeutics.
Discuss your idea ↗
02 / About us
Ferring Microbiome Inc. pioneers the development and manufacturing of innovative therapeutic solutions in the emerging field of microbiome science. Our company is driven by the belief that advancing microbiome-based interventions can transform approaches to gastrointestinal and systemic health.
We invest substantially in proprietary research, leveraging the MRT™ platform to enable robust, effective, and scalable solutions for restoring gut microbial balance. Our multidisciplinary team combines scientific rigor with industry know-how, building strategic collaborations and translating research findings into impactful products.
Strategically located at the intersection of research and manufacturing, we serve pharmaceutical, biotech, and academic partners pursuing breakthroughs in gut health. Our commitment to quality and innovation aims to accelerate the progression of microbiome therapies from discovery to patient-ready solutions.
Start a conversation ↗Practical guidance / 01
Our services are best suited for pharmaceutical companies, biotech innovators, academic researchers, and translational teams working in the field of microbiome science or therapeutics. We tailor our approach based on the project’s maturity and technical complexity. If you aim to advance gut microbiome research or bring products to market, our infrastructure and experience can support your pathway.
Practical guidance / 02
To make your enquiry productive, gather a clear outline of your scientific or manufacturing needs, target indications, timelines, and any initial data or protocols. The more context you provide upfront, the better we can assess technical fit and respond with relevant information.
Practical guidance / 03
We specialize in manufacturing and supporting development for microbiome-based therapies within regulatory frameworks. Clinical trials, direct patient services, or distribution are not covered. Scope and availability depend on current capacity, technical compatibility, and applicable regulatory standards—each proposal is reviewed individually.
Our perspective
The MRT™ platform anchors our approach to microbiome therapy, enabling restoration of gut flora through a tailored, modular methodology. By facilitating reproducibility and adaptable applications, MRT™ supports scientific advances and scalability from small-batch research to commercial production. Our focus on platform flexibility ensures partners can create customized, targeted interventions for diverse clinical needs.
03 / How to get started
Begin the process by reaching out to discuss your project, research interests, or manufacturing needs. Our team will review your objectives and answer preliminary questions, clarifying how our expertise fits your requirements. This initial step helps us understand the project scope and relevant technical or regulatory considerations.
Following the initial discussion, we engage in detailed review of the scientific, operational, and logistical needs. This feasibility analysis considers the specific goals, required resources, and development or manufacturing pathways involved. Our aim is to ensure realistic alignment between your project and our capabilities early in the conversation.
We provide tailored recommendations and, where interests align, outline a collaboration or service proposal. This includes next steps, estimated timelines, and necessary documentation for advancing your microbiome-based research or product. Direct communication ensures mutual clarity before any commitments—enquiries are always welcome.
04 / A little more detail
MRT™ is designed to restore healthy gut flora with a modular architecture, allowing flexible adaptation for various therapeutic needs. This supports reproducibility, precise targeting, and accelerated development from research to clinical application. Its design facilitates integration with existing pipelines and enhances scalability for larger production runs.
We support a range of projects involving research discovery, technology development, and manufacturing of microbiome-based therapeutics. Our capabilities extend from early-stage translational research to pilot and commercial-scale manufacturing, with a focus on projects requiring robust scientific and technical solutions in the gut microbiome field.
Our facility is equipped for contract manufacturing and technology transfer relating to microbiome-based therapies. Interested parties should enquire to discuss requirements, timelines, and regulatory expectations. The feasibility of collaborations depends on available capacity, technical fit, and the details of each proposal.
To start, contact our team with a summary of your project or interest. We’ll begin by clarifying your objectives, scientific or manufacturing needs, and any regulatory or technical parameters. A detailed assessment and discussion of fit will follow, leading to a tailored proposal if mutual interests and capabilities align.
We offer support related to the development and manufacturing of microbiome-based therapies, including technical advice, protocol development, and assistance navigating the regulatory landscape specific to our field. Direct clinical consulting or representation in regulatory submissions is not part of our documented offering; please contact us to discuss your specific needs.
05 / Contact us
If you’re investigating, developing, or seeking to produce microbiome-based therapies, we welcome your enquiry. Contact us to discuss scientific, technical, or partnership opportunities; our team will respond to clarify our expertise and explore collaboration in line with your objectives.
Email us ↗